[1] |
Yamamoto A, Suzuki S. Successful surgical treatment of a giant uterine leiomyoma: A case report[J]. Int J Surg Case Rep, 2021, 87:106416. doi: 10.1016/j.ijscr.2021.106416.
doi: 10.1016/j.ijscr.2021.106416
|
[2] |
Harris HR, Petrick JL, Rosenberg L. The epidemiology of uterine fibroids: Where do we go from here?[J]. Fertil Steril, 2022, 117(4):841-842. doi: 10.1016/j.fertnstert.2022.01.037.
doi: 10.1016/j.fertnstert.2022.01.037
pmid: 35277259
|
[3] |
Jonas HS, Masterson BJ. Giant uterine tumors: case report and review of the literature[J]. Obstet Gynecol, 1977, 50(1 Suppl): 2s-4s.
pmid: 876535
|
[4] |
姜文英, 曹保利. 巨大子宫肌瘤1例[J]. 实用临床医学, 2015, 16(10):52-52,55. doi: 10.13764/j.cnki.lcsy.2015.10.020.
doi: 10.13764/j.cnki.lcsy.2015.10.020
|
[5] |
子宫肌瘤的诊治中国专家共识专家组. 子宫肌瘤的诊治中国专家共识[J]. 中华妇产科杂志, 2017, 52(12):793-800. doi: 10.3760/cma.j.issn.0529-567x.2017.12.001
doi: 10.3760/cma.j.issn.0529-567x.2017.12.001
|
[6] |
Delgado B, Dreiher J, Braiman D, et al. P16, Ki67, P53, and WT1 Expression in Uterine Smooth Muscle Tumors: An Adjunct in Confirming the Diagnosis of Malignancy in Ambiguous Cases[J]. Int J Gynecol Pathol, 2021, 40(3):257-262. doi: 10.1097/PGP.0000000000000688.
doi: 10.1097/PGP.0000000000000688
|
[7] |
Brito L, Ueno NL, Machado MR. Does Big Mean Evil? Giant, but Benign Uterine Leiomyoma: Case Report and Review of the Literature[J]. Rev Bras Ginecol Obstet, 2021, 43(1):66-71. doi: 10.1055/s-0040-1721351.
doi: 10.1055/s-0040-1721351
|
[8] |
闫洪亮, 尚玉敏, 胡同秀, 等. 巨大子宫肌瘤合并深静脉血栓及肺栓塞一例并文献复习[J]. 中国妇产科临床杂志, 2020, 21(3):314-315. doi: 10.13390/j.issn.1672-1861.2020.03.036.
doi: 10.13390/j.issn.1672-1861.2020.03.036
|
[9] |
中国医师协会妇产科医师分会妇科肿瘤专业委员会学组. 实施腹腔镜下子宫(肌瘤)分碎术的中国专家共识[J]. 中国实用妇科与产科杂志, 2020, 36(7):626-632. doi: 10.19538/j.fk2020070113.
doi: 10.19538/j.fk2020070113
|
[10] |
刘懿, 柳露, 张旭梅, 等. 巨大子宫肌瘤并发下肢深静脉血栓及急性肺栓塞1例[J]. 实用妇产科杂志, 2021, 37(12):959-960. doi: 10.3760/cma.j.cmcr.2022.e04785.
doi: 10.3760/cma.j.cmcr.2022.e04785
|
[11] |
Ekkel E, Chandran T, Trpkovski M, et al. Management of phlegmasia cerulea dolens caused by a giant leiomyoma[J]. J Vasc Surg Cases Innov Tech, 2022, 8(2):240-243. doi: 10.1016/j.jvscit.2022.02.013.
doi: 10.1016/j.jvscit.2022.02.013
pmid: 35493345
|
[12] |
American College of Obstetricians and Gynecologists′ Committee on Practice Bulletins-Gynecology. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228[J]. Obstet Gynecol, 2021, 137(6):e100-e115. doi: 10.1097/AOG.0000000000004401.
doi: 10.1097/AOG.0000000000004401
pmid: 34011888
|
[13] |
Zhang J, Go VA, Blanck JF, et al. A Systematic Review of Minimally Invasive Treatments for Uterine Fibroid-Related Bleeding[J]. Reprod Sci, 2022, 29(10):2786-2809. doi: 10.1007/s43032-021-00722-z.
doi: 10.1007/s43032-021-00722-z
|
[14] |
Laughlin-Tommaso S, Barnard EP, AbdElmagied AM, et al. FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery[J]. Am J Obstet Gynecol, 2019, 220(2):174.e1-174.e13. doi: 10.1016/j.ajog.2018.10.032.
doi: 10.1016/j.ajog.2018.10.032
|
[15] |
Rovelli RJ, Cieri-Hutcherson NE, Hutcherson TC. Systematic review of oral pharmacotherapeutic options for the management of uterine fibroids[J]. J Am Pharm Assoc (2003), 2022, 62(3):674-682.e5. doi: 10.1016/j.japh.2022.02.004.
doi: 10.1016/j.japh.2022.02.004
pmid: 35277362
|